08:23 AM EDT, 08/08/2024 (MT Newswires) -- Roivant Sciences ( ROIV ) reported fiscal Q1 net income Thursday of $0.12 per diluted share, swinging from a loss of $0.38 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.26.

Revenue for the quarter ended June 30 was $55.1 million, compared with $21.6 million a year earlier.

Analysts surveyed by Capital IQ expected $29.6 million.

Price: 10.37, Change: +0.20, Percent Change: +1.97